Naperville, IL -- (SBWire) -- 09/17/2014 --Reportstack, provider of premium market research reports announces the addition of CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Venezuela market report to its offering
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Venezuela
Summary:
The publisher, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Venezuela. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Venezuela. It identifies the key trends in the countrys healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by team of industry experts.
The population of Venezuela grew from 27.7 million in 2008 to 29.8 million in 2013, mainly due to increasing life expectancy. Domestic production of medicines meets approximately 50% of the total demand of the Venezuelan population. The government has introduced the Mision Barrio Adentro program to provide universal healthcare access and Farmapatria to provide medicines on a discount up to 54%. The future growth in the pharmaceutical market will be dependent on the resolution of concerns related to inefficient patent protection laws, drug pricing policy, and dependency on imports. The countrys pharmaceutical market was approximately $10 billion in 2013 and is projected to reach $22.2 billion by 2020 at a CAGR of 12%. These positive growth trends can primarily be attributed to:
- Increasing elderly population
- Government initiatives in healthcare sector
Scope:
The report provides information on the healthcare, regulatory, and reimbursement landscape in Venezuela, and includes:
- Overview of the pharmaceutical market of Venezuela including the market size, market segmentation, key drivers and barriers for the market
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, GlaxoSmithkline, Sanofi, Novartis and Groupo Farma
- Insightful review of the reimbursement and regulatory landscape, with analysis covering details of the countrys healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Venezuelan healthcare market
Reasons to buy:
This report will enhance your decision-making capability by allowing you to:
- Develop business strategies by understanding the trends shaping and driving Venezuelas healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to affect Venezuelas healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in Venezuelas healthcare market
To view the table of contents for this market research report please visit
http://www.reportstack.com/product/171563/countryfocus-healthcare-regulatory-and-reimbursement-landscape-venezuela.html
Contact:
Roger Campbell
roger@reportstack.com
Naperville
Illinois
United States
Ph: 888-789-6604
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Venezuela